Theravance Biopharma
TBPH
TBPH
118 hedge funds and large institutions have $775M invested in Theravance Biopharma in 2020 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 36 increasing their positions, 51 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
30% less capital invested
Capital invested by funds: $1.11B → $775M (-$336M)
33% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 18
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
118
Holding in Top 10
–
Calls
$877K
Puts
$1.04M
Top Buyers
| 1 | +$54.2M | |
| 2 | +$8.13M | |
| 3 | +$3.62M | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$2.07M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.51M |
Top Sellers
| 1 | -$17.7M | |
| 2 | -$15.4M | |
| 3 | -$8.49M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$5.85M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$5.65M |